Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 40

Sort by

Sort Order Select

Journal Articles

Real-World Analysis of Patients with CLL Treated with Ibrutinib: A Retrospective Analysis of the Brazilian Registry of CLL

Verena Pfister, Fernanda de Morais Marques, Vinicius Campos de Molla, Flavia Parra, Mihoko Yamamoto, Rodrigo Santucci, Milton A. F. Aranha, Valeria Buccheri, Glaciano Ribeiro, Vera Figueiredo, Nelson Hamerschlak, Abel Costa Neto, Jayr Schmidt Filho, Talita Silveira, Adriana Scheliga, Matheus Vescovi Goncalves, Leila Perobelli, Carlos Chiattone, Celso Arrais-Rodrigues

Blood (2024) 144 (Supplement 1): 2348.

https://doi.org/10.1182/blood-2024-210706

Published: 2024

Journal Articles

Outcomes of Conservative Indication Criteria for First-Line Treatment in Chronic Lymphocytic Leukemia: Insights from the Brazilian Registry of CLL

Blood (2023) 142 (Supplement 1): 6534.

https://doi.org/10.1182/blood-2023-190590

Published: 2023

Journal Articles

Real-World Outcomes of Second-Line Chronic Lymphocytic Leukemia Treatments: Retrospective Analysis of the Brazilian Registry of CLL

Marcelo Pitombeira de Lacerda, Fernanda de Morais Marques, Verena Pfister, Flavia de Carvalho Parra, Vinicius Campos de Molla, Valeria Buccheri, Rafael Dezen Gaiolla, Laura Maria Fogliatto, Rodrigo Santucci, Marcelo Bellesso, Sérgio Costa Fortier, Talita M.B. Silveira, Glaciano Ribeiro, Nelson Hamerschlak, Mihoko Yamamoto, Matheus Vescovi Goncalves, Carlos S. Chiattone, Celso Arrais-Rodrigues

Blood (2022) 140 (Supplement 1): 7041–7042.

https://doi.org/10.1182/blood-2022-170872

Published: 2022

Journal Articles

Comparison of Clinical and Laboratory Features, Drug Availability, and Outcomes of CLL Patients Treated in Public or in Private Hospitals in Brazil: A Retrospective Analysis of the Brazilian Registry of CLL

Blood (2020) 136 (Supplement 1): 2.

https://doi.org/10.1182/blood-2020-142520

Published: 2020

Journal Articles

Favorable Outcome in CLL Patients Not Treated Despite Presenting Iwcll Criteria: A Retrospective Analysis of the Brazilian CLL Group

Fernanda de Morais Marques, Verena Pfister, Flavia Parra, Mihoko Yamamoto, MD PhD, Rodrigo Santucci Silva, MD, Marcelo Bellesso, MD, Vinicius Campos de Molla, MD, Ana Rita Da Fonseca, MD, Yana Novis, MD, Sérgio Costa Fortier, MD, Talita Silveira, MD PhD, Guilherme Brasil Duffles Amarante, MD, Valeria Buccheri, Matheus Vescovi, MD PhD, Carlos Sérgio Chiattone, MD PhD, Celso Arrais, MD PhD

Blood (2020) 136 (Supplement 1): 12.

https://doi.org/10.1182/blood-2020-142810

Published: 2020

Journal Articles

Classical Monocyte Deficiency Calculated By the Mono-Index Can Predict Mortality in Allogeneic Hematopoietic Stem Cell Transplantation Patients

Vinicius Campos de Molla, MD, Matheus Vescovi Gonçalves, MD PhD, Elisa Y Kimura, Vergilio Colturato, MD, Maura V Ikoma, MD PhD, Victor Gottardello Zecchin, MD, Adriana Seber, MD, Nelson Hamerschlak, MD PhD, Vanderson Rocha, MD PhD, Yana Novis, MD, Mihoko Yamamoto, MD PhD, Marcio Nucci, MD PhD, Celso Arrais-Rodrigues, MD PhD

Blood (2019) 134 (Supplement_1): 5666.

https://doi.org/10.1182/blood-2019-126221

Published: 2019

Journal Articles

NK CD56 bright CD16 neg reconstitution over Time (NK56-index) Significantly Impacts Long Term Outcome in Allogeneic Hematopoietic Stem Cell Transplantation

Dante Escorcio-Tavares, Vinicius Campos de Molla, MD, Elisa Y Kimura, Vergilio Colturato, MD, Maura V Ikoma, MD PhD, Victor Gottardello Zecchin, MD, Adriana Seber, MD, Nelson Hamerschlak, MD PhD, Vanderson Rocha, MD PhD, Yana Novis, MD, Mihoko Yamamoto, MD PhD, Marcio Nucci, MD PhD, Celso Arrais-Rodrigues, MD PhD, Matheus Vescovi Gonçalves, MD PhD

Blood (2019) 134 (Supplement_1): 3295.

https://doi.org/10.1182/blood-2019-128263

Published: 2019

Journal Articles

Metabolomic Profile in Patients with Autoimmune Hemolytic Anemia

Iara Baldim Rabelo, MD PhD, Akemi Kuroda Chiba, Pharmacist, MS, Elyse Moritz, Pharmacist, PhD, Melca Oliveira Barros, MD PhD, Ismael Dale Cotrim Guerreiro Silva, MD PhD, Jose Orlando Bordin, MD PhD, Maria de Lourdes Chauffaille, MD PhD, Mihoko Yamamoto, MD PhD, Celso Arrais, MD PhD

Blood (2018) 132 (Supplement 1): 3622.

https://doi.org/10.1182/blood-2018-99-116275

Published: 2018

Journal Articles

Alemtuzumab for Treatment-Naïve and Relapsed-Refractory Severe Acquired Aplastic Anemia

Nayara Ribeiro Guedes, Juliana Goncalves, MD, Marcelo Lacerda, MD, Maria Cristina Nunez, ANA RITA F B Medeiros, MD, Ana Carolina Kirchmeyer, Andre domingues Pereira, MD, Patricia Eiko Yamakawa, MD, Melca Oliveira Barros, MD PhD, Matheus Vescovi, MD PhD, Mihoko Yamamoto, MD PhD, Celso Arrais, MD PhD

Blood (2017) 130 (Supplement 1): 4961.

https://doi.org/10.1182/blood.V130.Suppl_1.4961.4961

Published: 2017

Journal Articles

Multiple Myeloma Cancer Stem Cells: Immunophenotypic and Functional Characterization, Gene Expression Profiling and Therapeutic Targets

Mariana Bleker de Oliveira, BSc, Paola Marino Dantonio, BSc, Veruska Lia Fook Alves, PhD, Rodrigo Carlini Fernando, BSc, Daniela Teixeira, MSc, Alexandre Basso, PhD, Mihoko Yamamoto, MD PhD, Gisele W. B. Colleoni, MD PhD

Blood (2016) 128 (22): 4434.

https://doi.org/10.1182/blood.V128.22.4434.4434

Published: 2016

Journal Articles

Heat Shock Protein 70 Inhibitor, Alone or in Combination with Bortezomib, Prevented Plasmacytoma Development in Immunodeficient Mice Transplanted with Myeloma Cell Lines

Mariana Bleker de Oliveira, BSc, Angela Isabel Eugenio, BSc, Veruska Lia Fook Alves, PhD, Daniela Zanatta, PhD, Mihoko Yamamoto, MD PhD, Bryan Eric Strauss, PhD, Gisele W. B. Colleoni, MD PhD

Blood (2016) 128 (22): 5658.

https://doi.org/10.1182/blood.V128.22.5658.5658

Published: 2016

Journal Articles

In Vitro JAK1/2 Inhibition, in Association with Bortezomib and Lenalidomide, Is Comparable with Bortezomib, Lenalidomide and Dexametasone: An Alternative for Multiple Myeloma Patients with JAK2 overexpression?

Mariana Bleker de Oliveira, BSc, Veruska Lia Fook Alves, PhD, Angela Isabel Eugenio, BSc, Rodrigo Carlini Fernando, BSc, Mihoko Yamamoto, MD PhD, Gisele W. B. Colleoni, MD PhD

Blood (2016) 128 (22): 5663.

https://doi.org/10.1182/blood.V128.22.5663.5663

Published: 2016

Journal Articles

Lactate dehydrogenase isoenzyme 3 and hemolysis in sickle cell anemia: a possible correlation?

Grazielle Mecabo, Mihoko Yamamoto, Thais Priscila Biassi, Maria Stella Figueiredo

Blood (2015) 125 (24): 3821–3822.

https://doi.org/10.1182/blood-2015-04-641522

Published: 2015

Journal Articles

Hydroxycarbamide Is Related with Higher Expression of Band-3 and CD59 in Sickle Erythrocytes

Grazielle Mecabo, postgraduate student, Mihoko Yamamoto, MD PhD, Eliza Y. S. Kimura, Fabio P. Guirao, Maria Stella Figueiredo, MD PhD

Blood (2014) 124 (21): 4913.

https://doi.org/10.1182/blood.V124.21.4913.4913

Published: 2014

Journal Articles

Dysregulation Of Bcl2 Family Proteins Induced By JAK2 V617F Mutation Contributes To The Abnormal Expansion Of Neoplastic Initiating Cells

Lorena Lobo Figueiredo-Pontes, MD, PhD, Robert S Welner, PhD, Yuta Mishima, PhD, Mihoko Yamamoto, MS, Ann Mullally, MD, Daniel G. Tenen, MD, Susumu Kobayashi, MD, PhD

Blood (2013) 122 (21): 2852.

https://doi.org/10.1182/blood.V122.21.2852.2852

Published: 2013

Journal Articles

Low Counts Of Natural Killer Cells CD56 bright CD16 negative After Engraftment Are Associated With Worse Survival In Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation

Matheus Vescovi Gonçalves, MD, Mihoko Yamamoto, MD, PhD, Eliza Y. S. Kimura, Vergilio Antonio Renzi Colturato, Maura Valerio Ikoma, MD, PhD, Marcos Mauad, MD, Mair Pedro de Souza, Paulo Guilherme Alvarenga Gomes de Oliveira, Thiago Xavier Carneiro, MD, Fabio R. Kerbauy, MD, PhD, Nelson Hamerschlak, MD, PhD, Yana Novis, MD, Valeria Cortez Ginani, MD, Adriana Seber, MD, Vanderson Rocha, MD, PhD, Alberto Orfao, MD, PhD, Celso Arrais Rodrigues, MD, PhD

Blood (2013) 122 (21): 4625.

https://doi.org/10.1182/blood.V122.21.4625.4625

Published: 2013

Journal Articles

Higher Counts Of Plasmacytoid Dendritic Cells In The Allograft Are Associated Increased Risk Of Acute Gvhd After Stem Cell Transplantation

Matheus Vescovi Gonçalves, MD, Mihoko Yamamoto, MD, PhD, Eliza Y. S. Kimura, Vergilio Antonio Renzi Colturato, Maura Valerio Ikoma, MD, PhD, Marcos Mauad, MD, Mair Pedro de Souza, Paulo Guilherme Alvarenga Gomes de Oliveira, Ana Paula Vaz Carvalho, Fabio R. Kerbauy, MD, PhD, Nelson Hamerschlak, MD, PhD, Yana Novis, MD, Valeria Cortez Ginani, MD, Adriana Seber, MD, Vanderson Rocha, MD, PhD, Alberto Orfao, MD, PhD, Celso Arrais Rodrigues, MD, PhD

Blood (2013) 122 (21): 4626.

https://doi.org/10.1182/blood.V122.21.4626.4626

Published: 2013

Journal Articles

Low Counts of Plasmacytoid Dendritic Cells After Engraftment Are Associated with Higher Early Transplantation-Related Mortality in Patients Receiving Unrelated HSCT

Matheus Vescovi GonÇalves, MD, Mihoko Yamamoto, MD, PhD, Vergílio Antônio Rensi Colturato, MD, Mair Pedro de Souza, Marcos Mauad, MD, Maura Valerio Ikoma, MD, PhD, Eliza Y. S. Kimura, Fabio P. Guirao, Nelson Hamerschlak, MD, Fabio R. Kerbauy, MD, Leonardo Raul Morelli, Yana Novis, MD, valeria Cortez Ginani, MD, Adriana Seber, MD, Vanderson Rocha, MD, PhD, Alberto Orfao, MD, PhD, Celso Arrais Rodrigues, MD, PhD

Blood (2011) 118 (21): 4541.

https://doi.org/10.1182/blood.V118.21.4541.4541

Published: 2011

Journal Articles

Time Elapsed From AML Diagnosis to Induction Chemotherapy Affects Overall Survival

Luis Arthur F. Pelloso, MD, PhD, Sandra Serson Rohr, MD, Mihoko Yamamoto, MD, PhD, Maria de Lourdes L. F. Chauffaille, MD, PhD

Blood (2011) 118 (21): 4262.

https://doi.org/10.1182/blood.V118.21.4262.4262

Published: 2011

Journal Articles

Evaluation of MAPK and PI3K/AKT Signaling Pathways In Adult Acute Lymphoblastic Leukemia

Gustavo Loureiro, MD, Daniella Bahia Kerbauy, MD, PhD, Maria de Lourdes, MD, PhD, L. F. Chauffaille, Maria Lucia M. Lee, MD, Franciele B. M. Candido, MD, Marçal C.A Silva, MD, Eliza Y. S. Kimura, Fabio P. Guirao, Denise C. Rezende, Mihoko Yamamoto, MD, PhD

Blood (2010) 116 (21): 3240.

https://doi.org/10.1182/blood.V116.21.3240.3240

Published: 2010

NARROW

Real-World Analysis of Patients with CLL Treated with Ibrutinib: A Retrospective Analysis of the Brazilian Registry of CLL

Outcomes of Conservative Indication Criteria for First-Line Treatment in Chronic Lymphocytic Leukemia: Insights from the Brazilian Registry of CLL

Real-World Outcomes of Second-Line Chronic Lymphocytic Leukemia Treatments: Retrospective Analysis of the Brazilian Registry of CLL

Comparison of Clinical and Laboratory Features, Drug Availability, and Outcomes of CLL Patients Treated in Public or in Private Hospitals in Brazil: A Retrospective Analysis of the Brazilian Registry of CLL

Favorable Outcome in CLL Patients Not Treated Despite Presenting Iwcll Criteria: A Retrospective Analysis of the Brazilian CLL Group

Classical Monocyte Deficiency Calculated By the Mono-Index Can Predict Mortality in Allogeneic Hematopoietic Stem Cell Transplantation Patients

NK CD56 bright CD16 neg reconstitution over Time (NK56-index) Significantly Impacts Long Term Outcome in Allogeneic Hematopoietic Stem Cell Transplantation

Metabolomic Profile in Patients with Autoimmune Hemolytic Anemia

Alemtuzumab for Treatment-Naïve and Relapsed-Refractory Severe Acquired Aplastic Anemia

Multiple Myeloma Cancer Stem Cells: Immunophenotypic and Functional Characterization, Gene Expression Profiling and Therapeutic Targets

Heat Shock Protein 70 Inhibitor, Alone or in Combination with Bortezomib, Prevented Plasmacytoma Development in Immunodeficient Mice Transplanted with Myeloma Cell Lines

In Vitro JAK1/2 Inhibition, in Association with Bortezomib and Lenalidomide, Is Comparable with Bortezomib, Lenalidomide and Dexametasone: An Alternative for Multiple Myeloma Patients with JAK2 overexpression?

Lactate dehydrogenase isoenzyme 3 and hemolysis in sickle cell anemia: a possible correlation?

Hydroxycarbamide Is Related with Higher Expression of Band-3 and CD59 in Sickle Erythrocytes

Dysregulation Of Bcl2 Family Proteins Induced By JAK2 V617F Mutation Contributes To The Abnormal Expansion Of Neoplastic Initiating Cells

Low Counts Of Natural Killer Cells CD56 bright CD16 negative After Engraftment Are Associated With Worse Survival In Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation

Higher Counts Of Plasmacytoid Dendritic Cells In The Allograft Are Associated Increased Risk Of Acute Gvhd After Stem Cell Transplantation

Low Counts of Plasmacytoid Dendritic Cells After Engraftment Are Associated with Higher Early Transplantation-Related Mortality in Patients Receiving Unrelated HSCT

Time Elapsed From AML Diagnosis to Induction Chemotherapy Affects Overall Survival

Evaluation of MAPK and PI3K/AKT Signaling Pathways In Adult Acute Lymphoblastic Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only